TERN-601
FALCON
Terns, Inc · Phase 2 · Completed · Enrollment 167
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| TERN-601 250 mg | 16 participants | 2 participants | 4 participants | n/r | 0 |
| TERN-601 500 mg (slow titration) | 17 participants | 10 participants | 4 participants | n/r | 0 |
| TERN-601 500 mg | n/r | n/r | n/r | n/r | n/r |
| TERN-601 750 mg | 20 participants | 11 participants | 1 participants | n/r | 0 |
| Matching Placebo | 3 participants | 0 participants | 2 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.